Company Data
Pharvaris N.V.
Ticker
PHVS
Current Price
$27.74 -6.41%
Market Cap
$1.9B
Price Target
Refer to Report
Volume
1.3M
52wk Range
$20.65 - $43.25
Overview
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.